01440cam2 22003731 450 SOBE0005120420230921133421.0067499202420160218d1993 |||||ita|0103 bagrcengGB<<7.: >>Scripta minoraXenophontranslated by E. C. MarchantConstitution of the AtheniansPseudo-Xenophontranslated by G. W. BowersockRistampaCambridgeMassachusettsLondonHarvard University press1993XLVII, 515, [1+ carta di tav.ill.17 cm<The >Loeb Classical Library183Testo orig. a fronte001LAEC000225972001 The *Loeb Classical Library183001SOBE000512052001 XenophonXenophonA60020002793207075253Goold, George P.SOBA00008455070Marchant, Edgar CardewAF00023396070Bowersock, Glen WarrenAF00022874070Xenophon <pseudo>SOBA00012507070ITUNISOB20230921RICAUNISOBUNISOB87090849SOBE00051204M 102 Monografia moderna SBNM870000971SI90849acquistocatenaccifUNISOBUNISOB20160218104033.020160218104058.0catenaccifScripta minora282995Constitution of the athenians1040928UNISOB02817nam 2200349z- 450 991056919620332120251017110114.0(CKB)5400000000050638(oapen)https://directory.doabooks.org/handle/20.500.12854/81840(oapen)doab81840(DNLM)9918282180106676(EXLCZ)99540000000005063820202205d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierAmyotrophic Lateral SclerosisAustraliaExon Publications20211 online resource (162 p.)0-645-00177-5 Amyotrophic lateral sclerosis is a fatal, progressive neurodegenerative disorder characterized by motor neuron cell death in the brain and spinal cord. The typical disease symptom is the rapid loss of muscle control, which eventually leads to the complete paralysis of voluntary muscles of the entire body. There is no curative treatment for amyotrophic lateral sclerosis. The rarity of the disease and the difficulties in accurate early diagnosis are the major challenges in the proper understanding of the disease and the development of curative therapy. This book brings together a team of experts, both clinicians and basic scientists, to provide a comprehensive understanding of amyotrophic lateral sclerosis, challenges, and approaches to combat this devastating disease. The clinical chapters provide excellent views of diagnosis, pathology, management, and the problem of diagnostic delay. The basic science chapters provide a comprehensive description of pathomechanisms and therapies with emphasis on dysfunctional astrocytes, impaired synaptic transmission, defective axonal transport, biomarkers, cell-based therapies, and gut microbiota. The book is primarily aimed at clinicians and basic scientists; however, it will likely be of interest to a wide audience interested in amyotrophic lateral sclerosis.MJNbicsscClinical Manifestation of Amyotrophic Lateral Sclerosis; Management of Amyotrophic Lateral Sclerosis; Diagnostic Delay in Amyotrophic Lateral Sclerosis; Astrocytes in Amyotrophic Lateral Sclerosis; Synaptic Transmission in Amyotrophic Lateral Sclerosis; Motoneuron Excitability Defects in Amyotrophic Lateral Sclerosis; Axonal Transport in Amyotrophic Lateral Sclerosis; Blood-based Biomarkers for Amyotrophic Lateral Sclerosis; Cell Therapy for Amyotrophic Lateral Sclerosis; Gut Microbiota in Amyotrophic Lateral SclerosisMJNAraki Toshiyukiedt1277390Araki ToshiyukiothBOOK9910569196203321Amyotrophic Lateral Sclerosis3010801UNINA